This approach demonstrates enhanced detection of immune activation signals in cancer treatment applications, indicating its potential impact on immunotherapy evaluation.
Background: Interferon-gamma (IFN-γ) is a key cytokine regulating cellular immune activation and is widely used as a functional biomarker in immunotherapy development. Standard ELISA method has limited sensitivity for early, low-level IFN-γ detection and does not effectively capture paracrine signaling in three-dimensional (3-D) models. To address these limitations, we developed IFN-γ-responsive luciferase reporter cell lines driven by a gamma-interferon activation site (GAS) promoter. Methods: Three cancer cell lines with high endogenous expression of checkpoint ligands (PD-L1, CD155, B7-H3) were engineered with a GAS-Luc2 construct. An additional GAS-Luc2 reporter cell line was generated from THP-1 cells for monocyte- and macrophage-related applications. Reporter activity was evaluated after stimulation with recombinant IFN-γ, T cell-conditioned media, and co-culture with primary T or NK cells. Assays were performed in 2-D and 3-D systems and compared with IFN-γ ELISA. CAR-T cells were also evaluated using both methods. Results: Reporter cells showed strong dose-dependent luciferase expression, with 100- to 250-fold increases after recombinant IFN-γ treatment and 50- to 100-fold induction with T-cell conditioned media. Co-cultures with primary immune cells produced 3- to 12-fold activation. Reporter signals remained robust in 3-D models and detected IFN-γ levels below the ELISA detection limit. In CAR-T assays, reporters identified early and low-level cytokine signaling not measurable by ELISA. Conclusions: GAS-Luc2 reporter cell lines provide a sensitive, quantitative, and scalable platform for monitoring IFN-γ signaling. Their superior performance over ELISA, especially for early activation and 3-D applications, supports their utility in immunotherapy evaluation, immune checkpoint studies, and CAR-T functional assessment. Citation Format: Hyeyoun Chang, John G. Foulke, Luping Chen, Catherine McManus, Meghan Sikes, Fang Tian. GAS-Luc2 reporter cell lines enable sensitive detection of interferon-gamma signaling for immune activation and CAR-T evaluation across 2D and 3D systems [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 6957.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: